About the Company
Acacia Research Corporation is a publicly traded American company based in New York City. Acacia partners with patent owners such as inventors and universities to license patents that are infringed. Roughly 95% of the company's business involves licensing infringed patents on behalf of patent owners to corporations through patent litigation. Acacia was incorporated in California in 1993 and is based in New York City. The company was consisted of two divisions: Acacia Technologies and CombiMatrix Group. The former covers the development, acquisition, licensing and enforcement of patented technologies. It creates a subsidiary company that acts as a special purpose entity for each set of patents that it enforces. The patent owner assigns the infringed patents to the subsidiary and the subsidiary then licenses the patents to companies who are infringing. Acacia and the patent owner split any revenues generated from licensing the patents on a 50/50 basis. Acacia's second division, CombiMatrix, constituted its life sciences business. This division, which Acacia held from 2002 until 2007, operated as a subsidiary. Invitae acquired CombiMatrix in 2017. Since the year 2000, Acacia has generated $1.4 billion in revenue from licensing patents and has paid out more than $731 million to inventors and other patent owners. The company has formed 233 known subsidiaries and has litigated 1,412 cases, four of which were not through a subsidiary.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ACTG News
Acacia Research to Release First Quarter 2024 Financial Results on May 9
Acacia Research Corporation (NASDAQ: ACTG) announced today it will release its first quarter 2024 financial results after the market closes on Thursday, May 9, 2024.
Acacia Research Announces Closing of Benchmark Energy's Transformative Acquisition in the Western Anadarko Basin
Acacia Research Corporation (Nasdaq: ACTG) (“Acacia”) today announced that its majority owned subsidiary, Benchmark Energy II, LLC (together with its subsidiaries, ...
Acacia Research (NASDAQ: ACTG)
Acacia Research Corp. engages in acquisition and development, and patents technologies through its subsidiaries. It operates through the Intellectual Property and Industrial Operations segments.
Acacia Research Corporation (NASDAQ:ACTG) Q4 2023 Earnings Call Transcript
Acacia Research Corporation misses on earnings expectations. Reported EPS is $0.00075 EPS, expectations were $0.07. ACTG ...
Acacia Research Corp ACTG
We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...
Acacia Research Corp. - Acacia Technologies
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Acacia Research Stock (NASDAQ:ACTG), Analyst Ratings, Price Targets, Predictions
Acacia Research Corp has a consensus price target of $7, established from looking at the 1 latest analyst ratings. The last 1 analyst ratings were released from Craig-Hallum on March 15 ...
Acacia Research: Q4 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Acacia Research Corp. (ACTG) on Thursday reported fourth-quarter net income of $74.8 million, after reporting a loss in the same period a year earlier.
Acacia Research Corp. Reg. Shs of Acacia Techs Aktie
Bitte entschuldigen Sie den Fehler. Sollte dieser Fehler erneut auftreten, kontaktieren Sie bitte unseren Kundeservice per E-Mail.
Acacia Research Corp ACTG
We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...
Acacia Research Corp. - Acacia Technologies
1 Day ACTG 0.95% DJIA 0.12% Russell 2K 0.00% Business/Consumer Services 0.06% ...
Acacia Research Corp
Analysts say investors should buy these undervalued stocks.
Loading the latest forecasts...